KRAS and malignant colon neoplasm: In our reporter assay, ~3 μM TMPyP4 incubated with cells for 72 h after transfection reduced human KRAS promoter activity by 25% but did not inhibit KRAS transcription in colon cancer HCT116 cells at a 12 μM concentration (Figure 6a).